Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

SELL
$31.71 - $38.95 $314,309 - $386,072
-9,912 Reduced 99.0%
100 $3,000
Q3 2023

Nov 13, 2023

SELL
$37.32 - $49.29 $169,059 - $223,283
-4,530 Reduced 31.15%
10,012 $377,000
Q1 2023

May 12, 2023

BUY
$37.58 - $52.57 $375,311 - $525,016
9,987 Added 219.25%
14,542 $589,000
Q4 2022

Feb 10, 2023

BUY
$49.7 - $57.71 $29,820 - $34,626
600 Added 15.17%
4,555 $232,000
Q1 2022

May 11, 2022

SELL
$76.85 - $89.45 $2,305 - $2,683
-30 Reduced 0.75%
3,955 $307,000
Q3 2021

Nov 04, 2021

BUY
$73.77 - $83.61 $2,213 - $2,508
30 Added 0.76%
3,985 $320,000
Q2 2020

Aug 12, 2020

SELL
$78.66 - $94.14 $57,107 - $68,345
-726 Reduced 15.51%
3,955 $340,000
Q2 2017

Aug 14, 2017

BUY
N/A
4,681
4,681 $284,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $18.2B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Tctc Holdings, LLC Portfolio

Follow Tctc Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tctc Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tctc Holdings, LLC with notifications on news.